These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 15736246

  • 1. Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model.
    Kipshidze NN, Porter TR, Dangas G, Yazdi H, Tio F, Xie F, Hellinga D, Wolfram R, Seabron R, Waksman R, Abizaid A, Roubin G, Iyer S, Colombo A, Leon MB, Moses JW, Iversen P.
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):389-94. PubMed ID: 15736246
    [Abstract] [Full Text] [Related]

  • 2. Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model.
    Kipshidze NN, Porter TR, Dangas G, Yazdi H, Tio F, Xie F, Hellinga D, Fournadjiev J, Wolfram R, Seabron R, Waksman R, Abizaid A, Roubin G, Iyer S, Leon MB, Moses JW, Iversen P.
    Cardiovasc Radiat Med; 2003 Mar; 4(3):152-9. PubMed ID: 14984716
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.
    Wessely R, Hausleiter J, Michaelis C, Jaschke B, Vogeser M, Milz S, Behnisch B, Schratzenstaller T, Renke-Gluszko M, Stöver M, Wintermantel E, Kastrati A, Schömig A.
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):748-53. PubMed ID: 15681298
    [Abstract] [Full Text] [Related]

  • 6. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
    Huang Y, Liu X, Wang L, Verbeken E, Li S, De Scheerder I.
    Int J Cardiovasc Intervent; 2003 Apr; 5(3):166-71. PubMed ID: 12959735
    [Abstract] [Full Text] [Related]

  • 7. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.
    Collingwood R, Gibson L, Sedlik S, Virmani R, Carter AJ.
    Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Restenosis is not associated with stent length in a pig model of coronary stent implantation.
    Koutouzis M, Papalois A, Kyrzopoulos S, Dafnomili P, Kyriakides ZS.
    Cardiol J; 2008 Jun; 15(5):458-62. PubMed ID: 18810722
    [Abstract] [Full Text] [Related]

  • 11. [Triptolide-eluting stent prevents porcine coronary artery in-stent restenosis by affecting PCNA and P27(kip1) expression].
    Lu DF, Huang J, Wu H, Yuan X, Zhang L.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):667-70. PubMed ID: 17545085
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
    Ma GS, Chen LJ, Chen Z, Ding S, Shen CX, Feng Y.
    Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of a tacrolimus-eluting stent to inhibit neointimal hyperplasia in a porcine coronary model.
    Huang Y, Salu K, Wang L, Liu X, Li S, Lorenz G, Wnendt S, Verbeken E, Bosmans J, Van de Werf F, De Scheerder I.
    J Invasive Cardiol; 2005 Mar; 17(3):142-8. PubMed ID: 15867441
    [Abstract] [Full Text] [Related]

  • 16. Local paclitaxel delivery after coronary stenting in an experimental animal model.
    Dommke C, Haase KK, Süselbeck T, Streitner I, Haghi D, Metz J, Borggrefe M, Herdeg C.
    Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059
    [Abstract] [Full Text] [Related]

  • 17. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R, Vogt F, Astafieva I, Fach C, Hristov M, Krott N, Seitz B, Kapurniotu A, Kwok C, Dewor M, Bosserhoff AK, Bernhagen J, Hanrath P, Hoffmann R, Weber C.
    J Am Coll Cardiol; 2006 May 02; 47(9):1786-95. PubMed ID: 16682302
    [Abstract] [Full Text] [Related]

  • 18. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
    Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, Mintz GS, Nagata S.
    J Am Coll Cardiol; 2006 May 16; 47(10):2108-11. PubMed ID: 16697331
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.